MEETINGS - Workshop entitled Economic Assessments in Clinical Trials: Design and Analysis (UK) September 2000:
This article was originally published in Clinica
Executive Summary
The Drug Information Association will hold a workshop entitled Economic Assessments in Clinical Trials: Design and Analysis at the Hotel Copthorne Tara, London, UK on September 18-19. Topics for discussion will include sample size estimation, analysis of resource and cost data, confidence intervals for cost effectiveness analysis, generalising results of multi-centre or multi-country trials to individual centres/countries, and willingness to pay and QALY assessment. For more information contact the Drug Information Association in Europe. Tel: +61 386 93 93. Fax: +61 386 93 90. Email: [email protected] www.diahome.org
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.